News

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 26 May 2021.

The Medical Research Future Fund (MRFF) grant opportunities calendar is now available.

A joint statement from the Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis society of Australia and New Zealand (THANZ) on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca.

The Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ) have released a joint statement on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of the COVID-19 Vaccine AstraZeneca.

Since COVID-19 began, people from indigenous communities around the world have been disproportionately affected by COVID-19.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 19 May 2021.

The Science of Immunisation: Questions and Answers guide has been updated. The guide looks at the benefits and safety of vaccines, what is in vaccines and what the future holds for vaccination.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 12 May 2021.

The Australian Government has announced an investment of $2.6 billion over the next four years for the Medical Research Future Fund (MRFF) in the 2021-22 Federal Budget. This continued investment will help drive innovation, improve health outcomes, and create jobs.

Health Budget 2021–22 information is now available.

A $17.7 billion reform package will provide higher quality and safer care for senior Australians.

The Australian Government is investing $2.3 billion in the National Mental Health and Suicide Prevention Plan – the largest Commonwealth mental health investment in Australia’s history.

Find accurate, evidence-based answers to questions about COVID-19 vaccines, including whether you should take blood thinning medication before having the AstraZeneca vaccine.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 4 May 2021

The next phase of Australia's COVID-19 vaccination rollout has commenced.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 28 April 2021

The Australian Commission on Safety and Quality in Health Carewill lead a review and update of the guiding principles for medication management in residential aged care facilities and in the community to support the safe and quality use of medicines.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on use of COVID-19 vaccines following review of vaccine safety data and benefits.

The Prime Minister provides an update from today's National Cabinet meeting where the COVID-19 vaccination program was discussed. Find out more.

A presentation with an update on Australia's COVID-19 vaccine rollout is now available to view or download.

The Medicare Benefits Schedule (MBS) Review Committee was established in March 2021 to review electrocardiogram (ECG) items introduced on 1 August 2020, following recommendations from the MBS Review Taskforce.

A statement from the Australian Health Protection Principal Committee (AHPPC) on continuous learning in managed quarantine for international arrivals.

There have been changes to the advice around the COVID-19 vaccines. The Pfizer vaccine is now preferred to the AstraZeneca vaccine for adults aged under 50 years.

Professor Brendan Murphy, Department of Health Secretary and Professor Paul Kelly, Australian Government Chief Medical Officer have released a joint statement about ATAGI's latest clinical advice on the AstraZeneca vaccine.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in response to new vaccine safety concerns.